Literature DB >> 26926692

Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Martin Grimm1, Johan Rieth2, Sebastian Hoefert2, Michael Krimmel2, Sven Rieth2, Peter Teriete3, Susanne Kluba2, Thorsten Biegner4, Adelheid Munz2, Siegmar Reinert2.   

Abstract

Analyzing the inflammatory microenvironment has become an important issue in the management of oral squamous cell carcinoma (OSCC). Pretreatment C-reactive protein (CRP) levels, leucocytes, monocytes, lymphocytes, neutrophils, basophils, eosinophils, platelets, neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) derived from the peripheral blood were analyzed. Receiver operating characteristic (ROC) curves determined a cut-off value for each parameter in 146 patients with OSCC compared with 93 controls and the results were associated with clinicopathological characteristics. CRP expression of tumors was measured by immunohistochemistry. ROC analysis determined cut-off values for CRP levels, leucocytes, monocytes, lymphocytes, neutrophils, NLR, dNLR, LMR, PLR and showed significant differences between the OSCC and control group. Compared with single laboratory tests calculated ratios were superior in measuring sensitivity and specificity of OSCC disease. NLR was significant directly associated and correlated with PLR. LMR was significant inversely associated and correlated with NLR and PLR. Immunohistochemical analysis did not show CRP expression of OSCCs. This study highlights the first analysis for cut-off values of pretreatment single laboratory tests and calculated ratios, which are strongly needed for a follow-up of cancer patients. Additionally, the calculated baselines can be used as a goal for successful immunotherapies in the future. The links between NLR, LMR, and PLR might be helpful for the clinical course (monitoring) of cancer patients and have been first described for OSCC in this study. Taken together, analyzing these data provides an additional practical guideline of further postoperative OSCC management.

Entities:  

Keywords:  DNLR; LMR; NLR; Oral squamous cell carcinoma; PLR

Mesh:

Substances:

Year:  2016        PMID: 26926692     DOI: 10.1007/s00405-016-3950-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  87 in total

Review 1.  Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

Authors:  R A Walker
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

2.  Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer.

Authors:  Matthias Kreppel; Hans Theodor Eich; Alexander Kübler; Joachim E Zöller; Martin Scheer
Journal:  J Surg Oncol       Date:  2010-10-01       Impact factor: 3.454

3.  Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.

Authors:  Alipasha Rassouli; Joe Saliba; Roberto Castano; Michael Hier; Anthony G Zeitouni
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

4.  Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.

Authors:  Reza Mehrazin; Robert G Uzzo; Alexander Kutikov; Karen Ruth; Jeffrey J Tomaszewski; Essel Dulaimi; Serge Ginzburg; Philip H Abbosh; Timothy Ito; Anthony T Corcoran; David Y T Chen; Marc C Smaldone; Tahseen Al-Saleem
Journal:  Urol Oncol       Date:  2014-07-11       Impact factor: 3.498

Review 5.  Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Olga Ace; Mairéad G McNamara; Mustafa Al-Mubarak; Francisco E Vera-Badillo; Thomas Hermanns; Boštjan Seruga; Alberto Ocaña; Ian F Tannock; Eitan Amir
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

Review 6.  The role of eosinophils and eosinophil cationic protein in oral cancer: a review.

Authors:  Michele Conceição Pereira; Denise Tostes Oliveira; Luiz Paulo Kowalski
Journal:  Arch Oral Biol       Date:  2010-11-26       Impact factor: 2.633

7.  Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.

Authors:  Patrizia Scapini; Lorella Nesi; Monica Morini; Elena Tanghetti; Mirella Belleri; Douglas Noonan; Marco Presta; Adriana Albini; Marco A Cassatella
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

8.  Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.

Authors:  Hsuan-Yeh Fang; Xin Yong Huang; Huei-Tzu Chien; Joseph Tung-Chieh Chang; Chun-Ta Liao; Jung-Ju Huang; Fu-Chan Wei; Hung-Ming Wang; I-How Chen; Chung-Jan Kang; Shiang-Fu Huang
Journal:  Laryngoscope       Date:  2013-04-25       Impact factor: 3.325

9.  Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.

Authors:  Hitoe Torisu-Itakura; Jonathan H Lee; Young Huynh; Xing Ye; Richard Essner; Donald L Morton
Journal:  J Immunother       Date:  2007 Nov-Dec       Impact factor: 4.456

10.  Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?

Authors:  Martin Grimm; Marcel Cetindis; Max Lehmann; Thorsten Biegner; Adelheid Munz; Peter Teriete; Wiebke Kraut; Siegmar Reinert
Journal:  J Transl Med       Date:  2014-07-21       Impact factor: 5.531

View more
  7 in total

1.  Systemic immune inflammation index in differentiated thyroid cancers.

Authors:  Ayhan Kars; Abdulkadir Sahin; Korhan Kılıc; Muhammed Sedat Sakat; Arzu Bilen
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

Review 2.  Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.

Authors:  Mircea Tampa; Madalina Irina Mitran; Cristina Iulia Mitran; Maria Isabela Sarbu; Clara Matei; Ilinca Nicolae; Ana Caruntu; Sandra Milena Tocut; Mircea Ioan Popa; Constantin Caruntu; Simona Roxana Georgescu
Journal:  J Immunol Res       Date:  2018-11-12       Impact factor: 4.818

3.  Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer.

Authors:  Qi Liu; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Clin Transl Med       Date:  2020-02-10

4.  The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma.

Authors:  Meng Ding; Yuxian Song; Junyan Jing; Mei Tian; Liang Ding; Qiang Li; Chongchong Zhou; Heng Dong; Yanhong Ni; Yongbin Mou
Journal:  Front Oncol       Date:  2021-09-06       Impact factor: 6.244

5.  Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers.

Authors:  Yating Tang; Guang Li; Shan Wu; Lingrong Tang; Ning Zhang; Jinzhao Liu; Shuo Zhang; Lei Yao
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

6.  The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.

Authors:  Olivia Knittelfelder; Daniela Delago; Gabriele Jakse; Katarzyna Lukasiak; Eva-Maria Thurner; Dietmar Thurnher; Martin Pichler; Wilfried Renner; Heidi Stranzl-Lawatsch; Tanja Langsenlehner
Journal:  Cancers (Basel)       Date:  2020-03-08       Impact factor: 6.639

Review 7.  Is There a Role for Basophils in Cancer?

Authors:  Giancarlo Marone; John T Schroeder; Fabrizio Mattei; Stefania Loffredo; Adriana Rosa Gambardella; Remo Poto; Amato de Paulis; Giovanna Schiavoni; Gilda Varricchi
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.